{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:51:07Z","timestamp":1781833867220,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073491"],"award-info":[{"award-number":["82073491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50008-0","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:45:43Z","timestamp":1777106743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanism of AGEs-RAGE axis inhibition of ferroptosis in type 2 diabetic colon cancer by regulatory CEACAM1"],"prefix":"10.1038","volume":"16","author":[{"given":"Kai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"50008_CR1","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/1878-0261.12438","volume":"13","author":"PNL Del","year":"2019","unstructured":"Del, P. N. L. et al. ,Molecular evidence of field cancerization initiated by diabetes in colon cancer patients. Mol. Oncol. 13, 857\u2013872 (2019).","journal-title":"Mol. Oncol."},{"key":"50008_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5604\/01.3001.0013.2588","volume":"91","author":"T Mi\u0142ek","year":"2019","unstructured":"Mi\u0142ek, T., Forysi\u0144ski, K. & Myrcha, P. Ciostek,Diabetes association of polyps and colon cancer. Pol. Przegl Chir. 91, 9\u201312 (2019).","journal-title":"Pol. Przegl Chir."},{"key":"50008_CR3","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/1878-0261.12531","volume":"13","author":"PNL Del","year":"2019","unstructured":"Del, P. N. L. et al. ,Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction. Mol. Oncol. 13, 1887\u20131897 (2019).","journal-title":"Mol. Oncol."},{"key":"50008_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fonc.2016.00210","volume":"6","author":"V Rosato","year":"2016","unstructured":"Rosato, V. et al. ,Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain. Front. Oncol. 6, 210 (2016).","journal-title":"Front. Oncol."},{"key":"50008_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ijc.34015","volume":"151","author":"S Harlid","year":"2022","unstructured":"Harlid, S. et al. ,Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases. Int. J. Cancer. 151, 348\u2013360 (2022).","journal-title":"Int. J. Cancer"},{"key":"50008_CR6","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s10620-012-2059-x","volume":"57","author":"L Sun","year":"2012","unstructured":"Sun, L. Yu,Diabetes mellitus is an independent risk factor for colorectal cancer. Dig. Dis. Sci. 57, 1586\u20131597 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"50008_CR7","doi-asserted-by":"publisher","first-page":"115886","DOI":"10.1016\/j.ab.2025.115886","volume":"703","author":"R Akasha","year":"2025","unstructured":"Akasha, R. et al. ,Inhibition of DNA glycoxidation by mannitol and Pyridoxamine: Implications for DNA-antibody development in diabetes and diabetic retinopathy. Anal. Biochem. 703, 115886 (2025).","journal-title":"Anal. Biochem."},{"key":"50008_CR8","doi-asserted-by":"crossref","unstructured":"Pal, R. and S. K. Bhadada,AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review,Bone 176 :116884. (2023).","DOI":"10.1016\/j.bone.2023.116884"},{"key":"50008_CR9","doi-asserted-by":"crossref","unstructured":"Yozgatli, K. et al. ,Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus. Diabet Med :1242\u20131248. (2018).","DOI":"10.1111\/dme.13651"},{"key":"50008_CR10","doi-asserted-by":"crossref","unstructured":"Ruiz, H. H. & Ramasamy, R. and A. M. Schmidt,Advanced Glycation End Products: Building on the Concept of the Common Soil in Metabolic Disease,Endocrinology 161 :bqz006. (2020).","DOI":"10.1210\/endocr\/bqz006"},{"key":"50008_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.arcmed.2017.07.001","volume":"48","author":"IU Jim\u00e9nez","year":"2017","unstructured":"Jim\u00e9nez, I. U. et al. ,Circulating Concentrations of Advanced Glycation end Products, its Association With the Development of Diabetes Mellitus. Arch. Med. Res. 48, 360\u2013369 (2017).","journal-title":"Arch. Med. Res."},{"key":"50008_CR12","doi-asserted-by":"crossref","unstructured":"Zeba, S. and A. Saheem,Protein Glycation: A Firm Link to Cause Metabolic Disease and their Complications. J Glycom. Lipidomics :05. (2015).","DOI":"10.4172\/2153-0637.1000127"},{"key":"50008_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.semcancer.2017.07.001","volume":"49","author":"S Ahmad","year":"2018","unstructured":"Ahmad, S. et al. ,AGEs, RAGEs and s-RAGE; friend or foe for cancer. Semin Cancer Biol. 49, 44\u201355 (2018).","journal-title":"Semin Cancer Biol."},{"key":"50008_CR14","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.bbagen.2017.02.024","volume":"1861","author":"R Deng","year":"2017","unstructured":"Deng, R. et al. ,Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression. Biochim. Biophys. Acta Gen. Subj. 1861, 1065\u20131074 (2017).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"50008_CR15","doi-asserted-by":"publisher","first-page":"1125745","DOI":"10.3389\/fonc.2023.1125745","volume":"13","author":"Z Chen","year":"2013","unstructured":"Chen, Z. Hong,Correlation of serum IGF-1, AGEs and their receptors with the risk of colorectal cancer in patients with type 2 diabetes mellitus. Front. Oncol. 13, 1125745 (2013).","journal-title":"Front. Oncol."},{"key":"50008_CR16","doi-asserted-by":"crossref","unstructured":"Azizian-Farsani, F., Abedpoor, N., Hasan, S. M., Gure, A. O. & Nasr-Esfahani, M. H. and K. Ghaedi,Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development,Front Oncol 10 :552283. (2020).","DOI":"10.3389\/fonc.2020.552283"},{"key":"50008_CR17","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/ijc.34449","volume":"152","author":"Z Mao","year":"2023","unstructured":"Mao, Z. et al. ,Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients. Int. J. Cancer. 152, 2257\u20132268 (2023).","journal-title":"Int. J. Cancer"},{"key":"50008_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12885-016-2213-5","volume":"16","author":"S Sakellariou","year":"2016","unstructured":"Sakellariou, S. et al. ,Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis. BMC Cancer. 16, 174 (2016).","journal-title":"BMC Cancer"},{"key":"50008_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1593\/tlo.09274","volume":"3","author":"A Calzolari","year":"2010","unstructured":"Calzolari, A. et al. ,Transferrin receptor 2 is frequently and highly expressed in glioblastomas. Transl Oncol. 3, 123\u2013134 (2010).","journal-title":"Transl Oncol."},{"key":"50008_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12951-022-01663-8","volume":"20","author":"T Luo","year":"2022","unstructured":"Luo, T., Wang, Y. & Wang, J. ,Ferroptosis assassinates tumor. J. Nanobiotechnol. 20, 467 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"50008_CR21","doi-asserted-by":"publisher","first-page":"113524","DOI":"10.1016\/j.biopha.2022.113524","volume":"153","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. ,Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets. Biomed. Pharmacother. 153, 113524 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"50008_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3892\/ol.2025.14890","volume":"29","author":"T Shimura","year":"2025","unstructured":"Shimura, T. et al. ,The prognostic importance of the negative regulators of ferroptosis, GPX4 and HSPB1, in patients with colorectal cancer. Oncol. Lett. 29, 144 (2025).","journal-title":"Oncol. Lett."},{"key":"50008_CR23","doi-asserted-by":"crossref","unstructured":"Wen, S. Y., Gao, R. R., Chen, Y. Y., Wang, Y. J. & Wang, X. T. and H. X. Liu,Brassinin from Brassica campestris L. inhibits colorectal cancer by inducing p62\/NRF2\/GPX4-regulated ferroptosis. Animal Model. Exp. Med :1\u201311. (2025).","DOI":"10.1002\/ame2.12521"},{"key":"50008_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1021\/acs.analchem.4c03065","volume":"97","author":"RK Mohanram","year":"2025","unstructured":"Mohanram, R. K., Thasu, S. O., Ganesh, G. V., Kannan, H. & Paulmurugan, R. Luciferase-Based Reporter System for Investigating GPx4-Mediated Ferroptosis and Its Therapeutic Implications in Diabetes. Anal. Chem. 97, 1059\u20131069 (2025).","journal-title":"Anal. Chem."},{"key":"50008_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00262-009-0740-5","volume":"59","author":"G Markel","year":"2010","unstructured":"Markel, G. et al. ,Systemic dysregulation of CEACAM1 in melanoma patients. CANCER IMMUNOL. IMMUN. 59, 215\u2013230 (2010).","journal-title":"CANCER IMMUNOL. IMMUN."},{"key":"50008_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/MPA.0b013e3180333ae3","volume":"34","author":"DM Simeone","year":"2007","unstructured":"Simeone, D. M. et al. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 34, 436\u2013443 (2007).","journal-title":"Pancreas"},{"key":"50008_CR27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.eururo.2009.05.040","volume":"57","author":"D Tilki","year":"2010","unstructured":"Tilki, D. et al. ,CEACAM1: a novel urinary marker for bladder cancer detection. Eur. Urol. 57, 648\u2013654 (2010).","journal-title":"Eur. Urol."},{"key":"50008_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cca.2015.09.005","volume":"450","author":"C Yang","year":"2015","unstructured":"Yang, C. et al. ,Assay of serum CEACAM1 as a potential biomarker for breast cancer. Clin. Chim. Acta. 450, 277\u2013281 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"50008_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1479-5876-6-78","volume":"6","author":"MS Keith","year":"2008","unstructured":"Keith, M. S. Amy,Interdependency of CEACAM-1, -3, -6, and \u2013\u20098 induced human neutrophil adhesion to endothelial cells. J. Transl Med. 6, 78 (2008).","journal-title":"J. Transl Med."},{"key":"50008_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10555-013-9444-6","volume":"32","author":"N Beauchemin","year":"2013","unstructured":"Beauchemin, N. Arabzadeh,Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev. 32, 643\u2013671 (2013).","journal-title":"Cancer Metastasis Rev."},{"key":"50008_CR31","doi-asserted-by":"publisher","first-page":"101296","DOI":"10.1016\/j.smim.2019.101296","volume":"42","author":"WM Kim","year":"2019","unstructured":"Kim, W. M., Huang, Y. H. & Gandhi, A. Blumberg,CEACAM1 structure and function in immunity and its therapeutic implications. Semin Immunol. 42, 101296 (2019).","journal-title":"Semin Immunol."},{"key":"50008_CR32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature13848","volume":"517","author":"YH Huang","year":"2015","unstructured":"Huang, Y. H. et al. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature 517, 386\u2013390 (2015).","journal-title":"Nature"},{"key":"50008_CR33","doi-asserted-by":"crossref","unstructured":"Huang, Y. H. et al. Author Correction:CEACAM1 regulates TIM-3-mediated tolerance and exhaustion,Nature 626 :E19. (2024).","DOI":"10.1038\/s41586-024-07164-y"},{"key":"50008_CR34","doi-asserted-by":"crossref","unstructured":"Leung, N., Turbide, C., Balachandra, B. & Marcus, V. and N. Beauchemin,Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1-\/- mice,Oncogene 27 :4943\u20134953. (2008).","DOI":"10.1038\/onc.2008.136"},{"key":"50008_CR35","doi-asserted-by":"crossref","unstructured":"Leung, N., Turbide, C., Olson, M., Marcus, V. & Jothy, S. and N. Beauchemin,Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis,Oncogene 25 :5527\u20135536. (2006).","DOI":"10.1038\/sj.onc.1209541"},{"key":"50008_CR36","first-page":"1622","volume":"16","author":"ZM Han","year":"2018","unstructured":"Han, Z. M. & Huang, H. M. Sun,Effect of CEACAM-1 knockdown in human colorectal cancer cells. Oncol. Lett. 16, 1622\u20131626 (2018).","journal-title":"Oncol. Lett."},{"key":"50008_CR37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. CD8\u2009+\u2009T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"50008_CR38","doi-asserted-by":"publisher","first-page":"1190333","DOI":"10.3389\/fimmu.2023.1190333","volume":"14","author":"H Jiashu","year":"2023","unstructured":"Jiashu, H. & Mengwei, W. Ziwen,Dysregulation in IFN-\u03b3 signaling and response: the barricade to tumor immunotherapy. Front. Immunol. 14, 1190333 (2023).","journal-title":"Front. Immunol."},{"key":"50008_CR39","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1158\/2159-8290.CD-20-1571","volume":"11","author":"D Wan","year":"2021","unstructured":"Wan, D. et al. ,Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation. Cancer Discov. 11, 1826\u20131843 (2021).","journal-title":"Cancer Discov"},{"key":"50008_CR40","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.dsx.2019.04.046","volume":"13","author":"A Abdel-Moneim","year":"2019","unstructured":"Abdel-Moneim, A., Semmler, M., Abdel-Reheim, E. S., Zanaty, M. I. & Addaleel, W. Association of glycemic status and interferon-\u03b3 production with leukocytes and platelet indices alterations in type2 diabetes. Diabetes Metab. Syndr. 13, 1963\u20131969 (2019).","journal-title":"Diabetes Metab. Syndr."},{"key":"50008_CR41","doi-asserted-by":"crossref","unstructured":"Eshaq, R. S. and N. R. Harris,The role of tumor necrosis factor-\u03b1 and interferon-\u03b3 in the hyperglycemia-induced ubiquitination and loss of platelet endothelial cell adhesion molecule-1 in rat retinal endothelial cells,Microcirculation 28 :e12717. (2021).","DOI":"10.1111\/micc.12717"},{"key":"50008_CR42","doi-asserted-by":"crossref","unstructured":"Ravichandran, R. et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation,Glycobiology 15 :16R-28R. (2005).","DOI":"10.1093\/glycob\/cwi053"},{"key":"50008_CR43","doi-asserted-by":"publisher","first-page":"eadp7302","DOI":"10.1126\/sciimmunol.adp7302","volume":"9","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. ,Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. Sci. Immunol. 9, eadp7302 (2024).","journal-title":"Sci. Immunol."},{"key":"50008_CR44","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1158\/1078-0432.CCR-22-1843","volume":"29","author":"SH Jeon","year":"2023","unstructured":"Jeon, S. H. et al. ,CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy. CLIN. CANCER RES. 29, 1794\u20131806 (2023).","journal-title":"CLIN. CANCER RES."},{"key":"50008_CR45","doi-asserted-by":"publisher","first-page":"e14337","DOI":"10.1111\/eci.14337","volume":"54","author":"L G\u00f6tz","year":"2024","unstructured":"G\u00f6tz, L., Rueckschloss, U., Najjar, S. M. & Erg\u00fcn, S. Kleefeldt,Carcinoembryonic antigen-related cell adhesion molecule 1 in cancer: Blessing or curse? EUR. J. CLIN. INVEST. 54, e14337 (2024).","journal-title":"EUR. J. CLIN. INVEST."},{"key":"50008_CR46","doi-asserted-by":"publisher","first-page":"1308264","DOI":"10.3389\/fimmu.2023.1308264","volume":"14","author":"Y Liang","year":"2023","unstructured":"Liang, Y., Wang, L., Ma, P., Ju, D. & Zhao, M. Shi,Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors. Front. Immunol. 14, 1308264 (2023).","journal-title":"Front. Immunol."},{"key":"50008_CR47","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/14728222.2024.2442437","volume":"28","author":"R Karami","year":"2024","unstructured":"Karami, R. et al. ,The emerging role of TIM-3 in colorectal cancer: a promising target for immunotherapy. EXPERT OPIN. THER. TAR. 28, 1093\u20131115 (2024).","journal-title":"EXPERT OPIN. THER. TAR"},{"key":"50008_CR48","doi-asserted-by":"crossref","unstructured":"Chen, X., Li, J., Kang, R. & Klionsky, D. J. and D. Tang,Ferroptosis:machinery and regulation,Autophagy 17 :2054\u20132081. (2021).","DOI":"10.1080\/15548627.2020.1810918"},{"key":"50008_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J. et al. ,Ferroptosis: past, present and future. Cell. Death Dis. 11, 88 (2020).","journal-title":"Cell. Death Dis."},{"key":"50008_CR50","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","volume":"14","author":"MM Gaschler","year":"2018","unstructured":"Gaschler, M. M. et al. ,FINO (2) initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat. Chem. Biol. 14, 507\u2013515 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"50008_CR51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R. & Kroemer, G. Tang,Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18, 280\u2013296 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"50008_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/JLB.3MA1220-815RRR","volume":"110","author":"K Rui","year":"2021","unstructured":"Rui, K., Nan, W., Wei, H. & Wen, B. Jie,IFN\u03b3-mediated repression of system Xc- drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. J. Leukoc. Biol. 110, 301\u2013314 (2021).","journal-title":"J. Leukoc. Biol."},{"key":"50008_CR53","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/jnc.12244","volume":"126","author":"P Urrutia","year":"2013","unstructured":"Urrutia, P. et al. ,Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J. Neurochem. 126, 541\u2013549 (2013).","journal-title":"J. Neurochem"},{"key":"50008_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3945\/an.110.1009","volume":"1","author":"AS Zhang","year":"2010","unstructured":"Zhang, A. S. Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis. Adv. Nutr. 1, 38\u201345 (2010).","journal-title":"Adv. Nutr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50008-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50008-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50008-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:03:16Z","timestamp":1781830996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50008-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50008"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50008-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures involving human samples were conducted in full compliance with the ethical standards outlined in the Declaration of Helsinki, and the study was approved by the Human Research Ethics Committee of the Second Hospital of Harbin Medical University (KY2024-032). All animal experiments were approved by the Animal Care and Use Committee of the Second Affiliated Hospital of Harbin Medical University (SYDW2022-100). All mice were maintained in pathogen-free facilities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"19145"}}